Clinuvel Pharmaceuticals Limited (CLVLF)

USD 7.45

(2.05%)

Long Term Debt Summary of Clinuvel Pharmaceuticals Limited

  • Clinuvel Pharmaceuticals Limited's latest annual long term debt in 2024 was 509.92 Thousand AUD , down 0.0% from previous year.
  • Clinuvel Pharmaceuticals Limited's latest quarterly long term debt in 2024 FY was 509.92 Thousand AUD , down -27.05% from previous quarter.
  • Clinuvel Pharmaceuticals Limited reported annual long term debt of 699.02 Thousand AUD in 2023, down -25.75% from previous year.
  • Clinuvel Pharmaceuticals Limited reported annual long term debt of 941.46 Thousand AUD in 2022, down -9.93% from previous year.
  • Clinuvel Pharmaceuticals Limited reported quarterly long term debt of 713.05 Thousand AUD for 2024 Q2, down 0.0% from previous quarter.
  • Clinuvel Pharmaceuticals Limited reported quarterly long term debt of 509.92 Thousand AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Clinuvel Pharmaceuticals Limited (2024 - 2000)

Historical Annual Long Term Debt of Clinuvel Pharmaceuticals Limited (2024 - 2000)

Year Long Term Debt Long Term Debt Growth
2024 509.92 Thousand AUD 0.0%
2023 699.02 Thousand AUD -25.75%
2022 941.46 Thousand AUD -9.93%
2021 1.04 Million AUD -5.6%
2020 1.1 Million AUD 546.49%
2019 171.26 Thousand AUD 0.0%
2018 - AUD 0.0%
2017 - AUD 0.0%
2016 - AUD 0.0%
2015 - AUD 0.0%
2014 - AUD 0.0%
2013 - AUD 0.0%
2012 - AUD 0.0%
2011 - AUD 0.0%
2010 - AUD 0.0%
2009 - AUD 0.0%
2008 - AUD 0.0%
2007 - AUD 0.0%
2006 - AUD 0.0%
2005 - AUD 0.0%
2004 - AUD 0.0%
2003 - AUD 0.0%
2002 - AUD 0.0%
2001 - AUD 0.0%
2000 - AUD 0.0%

Peer Long Term Debt Comparison of Clinuvel Pharmaceuticals Limited

Name Long Term Debt Long Term Debt Difference
Capstone Therapeutics Corp. 8.26 Million USD 93.83%
Skye Bioscience, Inc. 171.23 Thousand USD -197.8%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 70.952%
Nascent Biotech, Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -537.404%
ProtoKinetix, Incorporated - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -91.964%
Regen BioPharma, Inc. 149.61 Thousand USD -240.826%
CSL Limited 11.23 Billion USD 99.995%
Northwest Biotherapeutics, Inc. 20.31 Million USD 97.49%
Evofem Biosciences, Inc. 8000.00 USD -6274.038%
Rebus Holdings, Inc. - USD -Infinity%
Burzynski Research Institute, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 97.561%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -769.553%
Mesoblast Limited 100.29 Million USD 99.492%
Marizyme, Inc. 667.12 Thousand USD 23.565%
Genus plc 228.2 Million USD 99.777%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.693%
Therapeutic Solutions International, Inc. 5512.00 USD -9151.143%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 76.927%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 63.653%
IMV Inc. 27.39 Million USD 98.139%
AXIM Biotechnologies, Inc. 5.42 Million USD 90.603%
MultiCell Technologies, Inc. 36.43 USD -1399633.736%
ONE Bio Corp. 592.19 Thousand USD 13.893%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.083%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 77.092%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 58.488%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 8.054%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -1915.586%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 73.14%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -58.361%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -239.949%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -210.54%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 96.679%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -11343.514%
Genscript Biotech Corporation 287.12 Million USD 99.822%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -303.733%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -122.391%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD -122.004%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -47825.094%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -240.826%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -261.648%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 93.479%
SYBLEU INC 300 Thousand USD -69.974%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -38.172%
International Stem Cell Corporation 445 Thousand USD -14.589%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 93.743%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -11.581%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 56.079%
PureTech Health plc 18.25 Million USD 97.206%
Coeptis Therapeutics, Inc. 150 Thousand USD -239.949%
IXICO plc 275 Thousand USD -85.427%
IntelGenx Technologies Corp. 11.83 Million USD 95.693%
Gelesis Holdings, Inc. 26.3 Million USD 98.062%
CSL Limited 11.23 Billion USD 99.995%
Cellectis S.A. 36.21 Million USD 98.592%